Nephrocare Health Services
add_icon

Nephrocare Health Services

598.70
-6.40
(-1.06%)
Market Cap
6,007.40 Cr
PE Ratio
79.11
Volume
1,50,243.00
Day High - Low
615.55 - 596.00
52W High-Low
663.90 - 446.00
ann
Q1 Quarterly Results are out. Check out the updated financials2 days ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
6,007.40 Cr
EPS
8.48
PE Ratio
79.11
PB Ratio
5.45
Book Value
111.27
EBITDA
223.87
Dividend Yield
0.00 %
Return on Equity
11.49
Debt to Equity
0.53
Analyst Rating and Forecast
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Nephrocare Health Services Limited will attend an investor conference in Mumbai on June 18-19, 2026. Discussions will rely on publicly available information.
neutral
Nephrocare Health Services Limited will attend an investor meeting hosted by Bank of America on June 04, 2026, in Hyderabad. Discussions will rely on publicly available information.
neutral
Nephrocare Health Services Limited will attend an investor conference hosted by Choice Broking on June 11, 2026. The meeting will be held virtually and will focus on publicly available information.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,607.40
#1 26,932.79
53.21
#1 2,762.90
8.15
#1 510
-14.98
55.66
1,308.50
13,464.04
75.02
814.20
16.36
182
37.25
66.06
555.35
11,513.95
58.30
1,645.85
22.25
185
74.66
65.88
506.30
8,058.54
50.08
829.04
18.06
156
125.46
70.10
598.70
#5 6,007.40
#10 79.11
#4 998.85
#2 29.74
#6 62
#8 22.09
53.96
549.45
1,782.34
17.24
772.77
4.05
106
101.45
36.67
285.80
1,488.47
47.73
310.41
21.30
34
-13.89
45.91
1,241.20
1,065.28
18.08
111.60
28.72
48
65.93
46.82
307.25
977.38
33.46
1,170.80
-18.47
-134
101.06
59.61
445.35
870.33
#1 13.31
147.80
#1 134.60
19
#1 520.00
43.67
Growth Rate
Revenue Growth
29.74 %
Net Income Growth
-7.73 %
Cash Flow Change
87.26 %
ROE
35.34 %
ROCE
60.40 %
EBITDA Margin (Avg.)
-6.81 %

Quarterly Financial Results

Quarterly Financials
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
203
223
234
250
263
277
Expenses
153
168
180
182
199
215
EBITDA
50
55
54
68
64
62
Operating Profit %
22 %
23 %
21 %
26 %
23 %
19 %
Depreciation
18
19
20
23
22
26
Interest
5
6
6
45
6
3
Profit Before Tax
26
30
29
-1
36
33
Tax
6
5
5
9
4
3
Net Profit
20
25
24
-10
32
30
EPS in ₹
2.47
3.05
13.10
-1.12
3.43
3.03

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
2026
Total Assets
428
571
666
806
997
1,471
Fixed Assets
192
205
239
356
396
436
Current Assets
178
285
324
390
545
839
Capital Work in Progress
2
43
34
1
6
6
Investments
0
0
0
0
51
33
Other Assets
234
322
393
450
544
0
Total Equity & Liabilities
428
571
666
806
997
1,471
Current Liabilities
94
94
175
243
284
299
Non Current Liabilities
75
81
103
150
129
55
Total Equity
259
396
389
414
584
1,117
Reserve & Surplus
245
387
384
409
579
1,096
Share Capital
4
5
5
2
2
20

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
Net Cash Flow
5
6
-5
47
65
Investing Activities
-62
-130
-76
-52
-125
Operating Activities
32
14
11
72
135
Financing Activities
36
121
60
27
54

Share Holding

% Holding
Jul 2025
Dec 2025
Mar 2026
Promoter
79.05 %
63.85 %
63.85 %
FIIs
0.00 %
9.30 %
9.94 %
DIIs
0.00 %
8.10 %
8.65 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
5.92 %
5.08 %
Others
20.94 %
12.82 %
12.48 %
No of Share Holders
65
36
43,409

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
10 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2026 512.90 527.50
19 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 May 2026 529.25 642.10

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript2 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation2 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation2 days ago
Announcement under Regulation 30 (LODR)-Acquisition2 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation3 days ago
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation7 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome9 days ago
Re-Appointment Of Internal Auditor10 days ago
Issuance Of Corporate Guarantee10 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation10 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release10 days ago
Board Meeting Outcome for Outcome Of The Board Meeting Held On May 19 202610 days ago
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 14, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsMay 12, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 04, 2026
Board Meeting Intimation for Intimation Of Board Meeting For Considering Audited Financial Results Of The Company.May 04, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementApr 03, 2026
Announcement Under Regulation 30 (LODR)- Disclosure Of Litigation Filed By The CompanyApr 02, 2026
Closure of Trading WindowMar 25, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 16, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 19, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 18, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 18, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsFeb 12, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 12, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 11, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 10, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 10, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 10, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On February 10 2026Feb 10, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 07, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2026
Board Meeting Intimation for Considering And Approving Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended 31St December 2025.Jan 30, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsJan 27, 2026
Issuance Of Corporate Guarantee For And On Behalf Of Nephrocare Health Care Services Philippines Inc. Philippines Step-Down Wholly-Owned Subsidiary Not Exceeding USD 6.00 Million. Jan 15, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 15, 2026
We Would Like To Inform That Pursuant To The Listing Of Equity Shares Of The Company On The Recognized Stock Exchanges Namely BSE Limited And National Stock Exchange Of India Limited The CIN Of The Company Has Been Changed From U85100TG2009PLC066359 To L8Jan 15, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 08, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 07, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 07, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJan 05, 2026
Closure of Trading WindowDec 29, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Dec 23, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Dec 23, 2025
Appointment of Company Secretary and Compliance OfficerDec 22, 2025
Intimation Under Reg 8(2) Of SEBI (PIT) Reg 2015 Enclosed Is The Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information.Dec 22, 2025
Intimation Under Regulation 30(5) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulation 2015Dec 22, 2025

Technical Indicators

RSI(14)
Neutral
55.89
ATR(14)
Less Volatile
29.01
STOCH(9,6)
Neutral
43.89
STOCH RSI(14)
Neutral
31.15
MACD(12,26)
Bullish
0.91
ADX(14)
Strong Trend
25.81
UO(9)
Bearish
42.79
ROC(12)
Uptrend And Accelerating
6.65
WillR(14)
Neutral
-45.97